UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Toward Personalizing Care: Assessing Heterogeneity of Treatment Effects in Randomized Trials

JAMA : the journal of the American Medical Association, 2023-04, Vol.329 (13), p.1063

2023

Volltextzugriff (PDF)

Association Between Industry Marketing Payments and Prescriptions for PCSK9 (Proprotein Convertase Subtilisin/Kexin Type 9) Inhibitors in the United States

Circulation Cardiovascular quality and outcomes, 2021-05, Vol.14 (5), p.CIRCOUTCOMES120007521-e007521

2021

Volltextzugriff (PDF)

Out-of-pocket expenditure for administration of benzathine penicillin G injections for secondary prophylaxis in patients with rheumatic heart disease: A registry-based data from a tertiary care center in Northern India

Indian heart journal, 2021-03, Vol.73 (2), p.169-173

2021

Volltextzugriff (PDF)

Characteristics of Populations Excluded From Clinical Trials Supporting Intensive Blood Pressure Control Guidelines

Journal of the American Heart Association, 2021-04, Vol.10 (7), p.e019707-e019707

2021

Volltextzugriff (PDF)

From Innovation to Implementation

Journal of the American College of Cardiology, 2014-12, Vol.64 (24), p.2616-2618

Kazi, Dhruv S., MD, MSc, MS

2014

Volltextzugriff (PDF)

Antibiotic Prophylaxis Against Endocarditis Prior to Invasive Dental Procedures: Filling in the Gaps

Journal of the American College of Cardiology, 2022-09, Vol.80 (11), p.1042-1044

2022

Volltextzugriff (PDF)

Multiple substance use and blood pressure in women experiencing homelessness

Addictive behaviors reports, 2023-06, Vol.17, p.100483-100483, Article 100483

2023

Volltextzugriff (PDF)

A Delicate Balance

Journal of the American College of Cardiology, 2015-02, Vol.65 (5), p.477-479

2015

Volltextzugriff (PDF)

Ultralow-dose quadruple combination therapy: a cost-effective solution for hypertension control

Heart (British Cardiac Society), 2023-11, Vol.109 (22), p.1659-1660

2023

Volltextzugriff (PDF)

Who Is Rescuing Whom?: Dog Ownership and Cardiovascular Health

Circulation Cardiovascular quality and outcomes, 2019-10, Vol.12 (10), p.e005887-e005887

Kazi, Dhruv S.

2019

Volltextzugriff (PDF)

The Inflation Reduction Act and Access to High-Cost Cardiovascular Therapies

JAMA : the journal of the American Medical Association, 2023-11, Vol.330 (17), p.1619

2023

Volltextzugriff (PDF)

Accurately Predicting Cardiovascular Risk—and Acting on It

Annals of internal medicine, 2020-01, Vol.172 (1), p.61

2020

Volltextzugriff (PDF)

Rural-Urban Disparities: Diabetes, Hypertension, Heart Disease, and Stroke Mortality Among Black and White Adults, 1999-2018

Journal of the American College of Cardiology, 2021-03, Vol.77 (11), p.1480-1481

2021

Volltextzugriff (PDF)

Statins for Primary Prevention of Cardiovascular Disease

The Medical clinics of North America, 2017-07, Vol.101 (4), p.689-699

2017

Volltextzugriff (PDF)

Diabetes Screening by Race and Ethnicity in the United States: Equivalent Body Mass Index and Age Thresholds

Annals of internal medicine, 2022-06, Vol.175 (6), p.765-773

2022

Volltextzugriff (PDF)

Cost-effectiveness and affordability of novel cardiovascular therapies: what physicians need to know

Heart (British Cardiac Society), 2021-08, Vol.107 (15), p.1267-1268

2021

Volltextzugriff (PDF)

Cost-Effectiveness of Screening Ultrasound after a First, Febrile Urinary Tract Infection in Children Age 2-24 Months

The Journal of pediatrics, 2020-01, Vol.216, p.73-81.e1

2020

Volltextzugriff (PDF)

The American Heart Association’s Call to Action for Reducing the Global Burden of Rheumatic Heart Disease: A Policy Statement From the American Heart Association

Circulation (New York, N.Y.), 2020-11, Vol.142 (20), p.e358-e368

2020

Volltextzugriff (PDF)

Association of Medicaid Expansion With Cardiovascular Mortality

JAMA cardiology, 2019-07, Vol.4 (7), p.671

2019

Volltextzugriff (PDF)

The March Toward Improved Heart Failure Outcomes Requires an Emphasis on Affordability

JACC. Heart failure, 2024-07, Vol.12 (7), p.1238-1241

2024

Volltextzugriff (PDF)

Projected Impact of Nonpharmacologic Management of Stage 1 Hypertension Among Lower-Risk US Adults

Hypertension (Dallas, Tex. 1979), 2024-08, Vol.81 (8), p.1758-1765

2024

Volltextzugriff (PDF)

Tafamidis and the Paradox of Rare Disease Therapies

JAMA network open, 2024-09, Vol.7 (9), p.e2427219

2024

Volltextzugriff (PDF)

Use of Administrative Claims to Assess Outcomes and Treatment Effect in Randomized Clinical Trials for Transcatheter Aortic Valve Replacement: Findings From the EXTEND Study

Circulation (New York, N.Y.), 2020-07, Vol.142 (3), p.203-213

2020

Volltextzugriff (PDF)

Forecasting the Economic Burden of Cardiovascular Disease and Stroke in the United States Through 2050: A Presidential Advisory From the American Heart Association

Circulation (New York, N.Y.), 2024-07, Vol.150 (4)

2024

Volltextzugriff (PDF)

Forecasting the Burden of Cardiovascular Disease and Stroke in the United States Through 2050—Prevalence of Risk Factors and Disease: A Presidential Advisory From the American Heart Association

Circulation (New York, N.Y.), 2024-07, Vol.150 (4)

2024

Volltextzugriff (PDF)

1 – 25 von 143

Suche als RSS-Feed

Aktive Filter

ThemaHumans

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(133)
Mit Volltextzugriff
(109)

Publikationsform

Artikel
(142)
Buchkapitel
(1)

Sprache

Englisch
(143)
Japanisch
(9)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

Toward Personalizing Care: Assessing Heterogeneity of Treatment Effects in Randomized Trials

Association Between Industry Marketing Payments and Prescriptions for PCSK9 (Proprotein Convertase Subtilisin/Kexin Type 9) Inhibitors in the United States

Out-of-pocket expenditure for administration of benzathine penicillin G injections for secondary prophylaxis in patients with rheumatic heart disease: A registry-based data from a tertiary care center in Northern India

Characteristics of Populations Excluded From Clinical Trials Supporting Intensive Blood Pressure Control Guidelines

From Innovation to Implementation

Antibiotic Prophylaxis Against Endocarditis Prior to Invasive Dental Procedures: Filling in the Gaps

Multiple substance use and blood pressure in women experiencing homelessness

A Delicate Balance

Ultralow-dose quadruple combination therapy: a cost-effective solution for hypertension control

Who Is Rescuing Whom?: Dog Ownership and Cardiovascular Health

The Inflation Reduction Act and Access to High-Cost Cardiovascular Therapies

Accurately Predicting Cardiovascular Risk—and Acting on It

Rural-Urban Disparities: Diabetes, Hypertension, Heart Disease, and Stroke Mortality Among Black and White Adults, 1999-2018

Statins for Primary Prevention of Cardiovascular Disease

Diabetes Screening by Race and Ethnicity in the United States: Equivalent Body Mass Index and Age Thresholds

Cost-effectiveness and affordability of novel cardiovascular therapies: what physicians need to know

Cost-Effectiveness of Screening Ultrasound after a First, Febrile Urinary Tract Infection in Children Age 2-24 Months

The American Heart Association’s Call to Action for Reducing the Global Burden of Rheumatic Heart Disease: A Policy Statement From the American Heart Association

Association of Medicaid Expansion With Cardiovascular Mortality

The March Toward Improved Heart Failure Outcomes Requires an Emphasis on Affordability

Projected Impact of Nonpharmacologic Management of Stage 1 Hypertension Among Lower-Risk US Adults

Tafamidis and the Paradox of Rare Disease Therapies

Use of Administrative Claims to Assess Outcomes and Treatment Effect in Randomized Clinical Trials for Transcatheter Aortic Valve Replacement: Findings From the EXTEND Study

Forecasting the Economic Burden of Cardiovascular Disease and Stroke in the United States Through 2050: A Presidential Advisory From the American Heart Association

Forecasting the Burden of Cardiovascular Disease and Stroke in the United States Through 2050—Prevalence of Risk Factors and Disease: A Presidential Advisory From the American Heart Association

Aktive Filter

Suchergebnisse filtern